3 Results for "

KRAS-mutant MIA PaCa-2

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "KRAS-mutant MIA PaCa-2" in MCE Product Catalog:

Cat. No.: HY-175326
CAS No.: 2767633-04-3
Target:  

SOS1

Research Areas:  

Cancer

SOS1-IN-21 is an orally active inhibitor of son of Sevenless 1 (SOS1) with an IC50 of 15 nM. SOS1 is a guanine nucleotide exchange factor (GEF) that activates KRAS by facilitating the exchange of GDP for GTP. SOS1-IN-21 exhibits potent antiproliferative activity, with IC50 values of 16 nM in NCI-H358 and 17 nM in Mia Paca-2 cell proliferation assays. SOS1-IN-21 exhibits significant antitumor activity in the Mia Paca-2 xenograft model. SOS1-IN-21 can be used for the study of KRAS mutant tumors, such as pancreatic cancer .
loading...
    loading...
Cat. No.: HY-149607
CAS No.: 2802453-88-7
Target:  

SHP2

Research Areas:  

Cancer

SHP2-IN-22 is SHP2 allosteric inhibitor with an IC50 value of 17.7 nM. SHP2-IN-22 inhibits the proliferation, migration, and invasion of MIA PaCa-2 pancreatic cancer cells. SHP2-IN-22 can be used for Kirsten rat sarcoma viral oncogene (KRAS) mutant cancer research .
loading...
    loading...
Cat. No.: HY-189287
Target:  

STAT Autophagy

Research Areas:  

Cancer

STAT3 antagonist-1 is a selective STAT3 antagonist. STAT3 antagonist-1 induces Autophagy-associated cell death. STAT3 antagonist-1 inhibits cancer stemness and epithelial-mesenchymal transition. STAT3 antagonist-1 can be used for research on pancreatic cancer and colorectal cancer .
loading...
    loading...